Pancreatic Cancer Stage IV Clinical Trials in Shanghai, Shanghai Municipality
2 recruitingShanghai, Shanghai Municipality, China
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Prospective, Randomized, Double-blinded, Multi-center Clinical Trial to Evaluate the Efficiency and Safety of Anti-PD1 Antibody (Camrelizumab) Combined With Paclitaxel(Albumin Bound) and Gemcitabine as First-line Therapy in Patients With Metastatic Pancreatic Cancer
Pancreatic Cancer Stage IVPancreatic Cancer Metastatic
RenJi Hospital401 enrolled6 locationsNCT04674956
Recruiting
Phase 3
Thalidomide to Chemotherapy Related Nausea and Vomiting in Pancreatic Cancer
Pancreatic Cancer Stage IV
Fudan University100 enrolled1 locationNCT06017284